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Background: In cardiac ventricular muscle cells, the presence of voltage-gated sodium
channels Nav1.5 at the lateral membrane depends in part on the interaction between
the dystrophin–syntrophin complex and the Nav1.5 C-terminal PDZ-domain-binding
sequence Ser-Ile-Val (SIV motif). α1-Syntrophin, a PDZ-domain adaptor protein,
mediates the interaction between Nav1.5 and dystrophin at the lateral membrane
of cardiac cells. Using the cell-attached patch-clamp approach on cardiomyocytes
expressing Nav1.5 in which the SIV motif is deleted (1SIV), sodium current (INa)
recordings from the lateral membrane revealed a SIV-motif-independent INa. Since
immunostaining has suggested that Nav1.5 is expressed in transverse (T-) tubules, this
remaining INa might be carried by channels in the T-tubules. Of note, a recent study
using heterologous expression systems showed that α1-syntrophin also interacts with
the Nav1.5 N-terminus, which may explain the SIV-motif independent INa at the lateral
membrane of cardiomyocytes.
Aim: To address the role of α1-syntrophin in regulating the INa at the lateral membrane
of cardiac cells.
Methods and Results: Patch-clamp experiments in cell-attached configuration were
performed on the lateral membranes of wild-type, α1-syntrophin knockdown, and
1SIV ventricular mouse cardiomyocytes. Compared to wild-type, a reduction of the
lateral INa was observed in myocytes from α1-syntrophin knockdown hearts. Similar
to 1SIV myocytes, a remaining INa was still recorded. In addition, cell-attached INa
recordings from lateral membrane did not differ significantly between non-detubulated
and detubulated 1SIV cardiomyocytes. Lastly, we obtained evidence suggesting that
cell-attached patch-clamp experiments on the lateral membrane cannot record currents
carried by channels in T-tubules such as calcium channels.
Conclusion: Altogether, these results suggest the presence of a sub-pool of
sodium channels at the lateral membrane of cardiomyocytes that is independent
of α1-syntrophin and the PDZ-binding motif of Nav1.5, located in membrane
domains outside of T-tubules. The question of a T-tubular pool of Nav1.5 channels,
however, remains open.
Keywords: voltage-gated sodium channel, lateral membrane of cardiomyocytes, α1-syntrophin, dystrophin,
electrophysiology
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INTRODUCTION
The sarcolemma of rod-shaped adult ventricular cardiomyocytes
can be divided into two principal regions. Firstly, the intercalated
disc (ID) allows the electrical and physical coupling between
adjacent cardiac cells via ID-ID connections. Secondly, the lateral
membrane, including transverse (T-) tubules, contains focal
adhesions crucial for the interaction between cardiomyocytes and
the extracellular matrix (Kaprielian and Severs, 2000; Noorman
et al., 2009; Vermij et al., 2017). The voltage-gated sodium
channel Nav1.5 is expressed in these membrane domains. Nav1.5
is the major isoform of the Nav1.x family in cardiomyocytes
(Chevalier et al., 2018). These channels are involved in the
generation and propagation of the cardiac action potential (AP)
(Gavillet et al., 2006; Petitprez et al., 2011). A few years ago,
we and other groups investigating Nav1.5 started to unveil
the complex localization of this channel in cardiac cells. We
showed that at least two pools of Nav1.5 channels are present
in murine ventricular cardiomyocytes based on their expression
pattern and interaction with cytoplasmic proteins (Abriel et al.,
2015). The first pool is located at the ID and plays a crucial
role in the propagation of the electrical impulse. Based on
results from heterologous expression systems and transfected
cardiac cells, the regulation of this pool has been proposed
to depend on SAP97 (synapse-associated protein 97), although
in vivo experiments using cardiac-specific SAP97 knockdown
mice did not support such observations (Petitprez et al., 2011;
Milstein et al., 2012; Gillet et al., 2015). Recently, Makara et al.
(2014) have convincingly shown the crucial role of ankyrin-
G in the regulation and targeting of Nav1.5 channel at the ID
in vivo. The second pool of Nav1.5 channels has been described
outside the ID domain comprising the lateral membrane and
the T-tubular system (Gavillet et al., 2006; Albesa et al., 2011;
Shy et al., 2014). Contrary to what was thought commonly,
the presence of Nav1.5 channels at the lateral membrane seems
to be important for cardiac conduction (Baba et al., 2005;
Shy et al., 2014). At the lateral membrane, the presence of
Nav1.5 channels mainly depends on the protein dystrophin
and the PDZ-binding motif of Nav1.5 comprising its last three
C-terminal amino acids Ser, Ile, and Val (SIV). The stability
of Nav1.5 at the lateral membrane has been shown to depend
on the interaction between the dystrophin–syntrophin complex
and the SIV motif (Gavillet et al., 2006; Shy et al., 2014).
In this interaction, syntrophin, containing a PDZ domain, act
as an adaptor protein between the SIV motif of Nav1.5 and
dystrophin. Depending on the species, dystrophin can interact
with different isoforms of syntrophin (Iwata et al., 2005). The
syntrophin family comprises five isoforms of ∼60 kD each: α1,
ß1, ß2, γ1, and γ2. α1-Syntrophin is abundantly expressed in
mouse heart (Yang et al., 1995). The γ-isoforms are mainly
expressed in the brain and skeletal muscle. α- and ß- isoforms are
expressed in many tissues including the heart. In hamster, rat, and
canine ventricular cardiomyocytes, dystrophin has been shown
to interact preferentially with the α1-, β1-, and β2-isoforms of
syntrophin (Iwata et al., 2005). In human and rabbit ventricles,
mainly the α1-isoform interacts with dystrophin (Iwata et al.,
2005). Using the cell-attached patch-clamp recording method
on ventricular cardiomyocytes from genetically modified mice
expressing Nav1.5 lacking the SIV motif (1SIV mouse model),
a ∼60% reduction, but not an abolition, of INa has been
observed at the lateral membrane (Shy et al., 2014). In addition,
the biophysical properties of the remaining INa at the lateral
membrane of 1SIV myocytes were similar to the wild-type cells
from littermate mice (Shy et al., 2014). Shy et al. (2014) proposed
that this remaining current originates from Nav1.5 channels at
the T-tubules. However, the presence of Nav1.5 in T-tubular
system is still under debate. Although immunofluorescence
staining for Nav1.5 has shown a T-tubular-like pattern in
ventricular cardiomyocytes, other experiments suggest that other
Nav1.x isoforms might be the main isoforms in this structure
(Brette and Orchard, 2006; Westenbroek et al., 2013; Shy et al.,
2014). Interestingly, Matamoros and colleagues, have shown in
heterologous expression systems that α1-syntrophin cannot only
interact with the C-terminal SIV motif but also with the sequence
comprising three N-terminal amino acids Ser, Leu, Ala (SLA)
of Nav1.5 channels (Matamoros et al., 2016). Based on this
observation, the remaining INa observed on the lateral membrane
of 1SIV mice could also depend on α1-syntrophin interacting
with Nav1.5 through the N-terminal SLA motif.
Taken together, one might explain the remaining INa outside
the ID in 1SIV ventricular cardiomyocytes as follows: (1) Nav1.5
channels also interact with the dystrophin–syntrophin complex
via another mechanism; and/or (2) a subset of Nav1.5 channels
at the lateral membrane are independent of the dystrophin–
syntrophin complex; and/or (3) Nav1.5 channels are present
inside the T-tubular system. In this work, we aimed to test
these hypotheses.
MATERIALS AND METHODS
All experiments involving animals were performed according
to the Swiss Federal Animal Protection Law and had been
approved by the Cantonal Veterinary Administration, Bern. This
investigation conforms to the Guide for the Care and Use of
Laboratory Animals, published by the US National Institutes of
Health (NIH publication no. 85–23, revised 1996).
Generation of Constitutive 1SIV
(Scn5a-p.S2017Stop) Knockin Mice
Generation of mice containing the 1SIV knockin deletion
was accomplished through the Cre/lox technique and
homologous recombination. Briefly, the serine 2017 residue
was mutated to a stop codon and a silent EcoRV site was
introduced within the 3′ UTR to allow genotyping. Heterozygous
Scn5a-p.S2017STOP mice were crossbred to obtain homozygous
Scn5a-p.S2017STOP mice. Wild-type littermates served as
control mice (Shy et al., 2014).
Generation of Constitutive
Cardiac-Specific α1-Syntrophin
Knockdown Mice
To study the function of α1-syntrophin (Sntα1), a conditional
mouse model was generated that allows tissue or time-point
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specific inactivation of the Snta1 gene by the use of the
Cre-/loxP-system. The design of the mouse model is based on a
modified Snta1 locus with two loxP sites flanking part of Snta1
exon1. One loxP site is inserted in the 5′ UTR in exon1, whereas
the second loxP site is located in intron 1. Upon breeding with
a heart-specific Cre-transgenic mouse line (i.e., MHC-Cre), the
coding region on exon 1 of Snta1 is deleted, restricted to the
cardiac muscle that is studied. For the introduction of loxP
sites into the Snta1 locus, a targeting vector (pSnta1 TV) was
generated that contained homology regions of 2.2 kb (short
homology region) and 5.6 kb (long homology region). The 3′
loxP site was inserted together with an FRT-flanked neomycin
cassette into a KpnI restriction site 269 bp downstream of Snta1
exon 1. The 5′ loxP site was inserted 50 bp downstream of the
start of exon 1 and 78 bp upstream of the ATG start codon in the
5′ untranslated region (5′ UTR). In total a region of 639 bp was
flanked by loxP sites, containing the coding part of Snta1 exon 1.
After transfection of 20 mg of the targeting vector into 107 129Ola
derived embryonic stem cells and selection with 200 mg/ml
G418 for 10 days, 100 clones were isolated and screened for
insertion into the Snta1 locus via Southern blot analysis using PstI
digested genomic DNA and a 5′ external probe (Supplementary
Figure S1A). Eight positive clones were identified and further
analyzed by Southern blot using PstI digested genomic DNA
and a 3′ external probe (Supplementary Figure S1B). Two
clones with a correct karyotype were injected into C57BL/6
derived blastocysts. Male mice with a high degree of coat color
chimerism were mated to Flp-deleter mice (C57Bl/6 background)
to generate heterozygous Snta1-flox mice. For genotyping, two
primers flanking the 5′ loxP site were used (Supplementary
Figure S1A). Primers E072.32 (5′-ACGAGCTACGGTCCAATC-
3′) and E072.33 (5′-ATCTTCGCCTCGAAGTCC-3′) detect a
391 bp fragment in the wild-type allele, whereas the insertion
of the loxP site in the Snta1-flox allele results in a slightly larger
fragment of 437 bp.
Cell Line Preparations
Human embryonic kidney (HEK-293) cells were cultured in
DMEM (Gibco, Basel, Switzerland) supplemented with 10% FBS,
0.5% penicillin, and streptomycin (10,000 U/mL) at 37◦C in a 5%
CO2 incubator.
Transfections
For electrophysiological studies, T25 cm2 flasks of HEK-293 cells
were transiently co-transfected using Jet-Pei R© reagent (Polyplus-
transfection SA, Illkirch, France) with 10 µg of human Nav1.4
cDNA. All transfections included 0.3 µg of cDNA encoding
CD8. For patch clamp experiments, anti-CD8 beads (Dynal R©,
Oslo, Norway) were used. Only cells decorated with anti-CD8
beads were analyzed.
Isolation of Mouse Ventricular Myocytes
Single cardiomyocytes were isolated according to a modified
procedure of established enzymatic methods (Gavillet et al.,
2006). Briefly, mice were euthanized by cervical dislocation.
Hearts were rapidly excised, cannulated and mounted on a
Langendorff column for retrograde perfusion at 37◦C. Hearts
were rinsed free of blood with a nominally Ca2+-free solution
containing (in mM): 135 NaCl, 4 KCl, 1.2 MgCl2, 1.2
NaH2PO4, 10 HEPES, 11 glucose, pH 7.4 (NaOH adjusted),
and subsequently digested by a solution supplemented with
50 µM Ca2+ and collagenase type II (1 mg/mL, Worthington,
Allschwil, Switzerland) for 15 min. Following digestion, the
atria were removed and the ventricles transferred to nominally
Ca2+-free solution, where they were minced into small pieces.
Single cardiac myocytes were liberated by gentle trituration of
the digested ventricular tissue and filtered through a 100 µm
nylon mesh. Ventricular mouse cardiomyocytes were used
after an extracellular calcium increase procedure to avoid
calcium overload when applying extracellular solutions in
electrophysiology assays.
Detubulation
Isolated cardiomyocytes were detubulated via osmotic shock
using formamide solution (Brette et al., 2002). Briefly, cardiac
cells were suspended in 2 mL of 1.5 M formamide solution
for 15 min at room temperature (RT) then washed twice
with an extracellular solution before use. For morphological
experiments, 1 µM di-8 ANEPPS, diluted in dimethyl sulfoxide
containing pluronic F-127, was applied to living cardiomyocytes
for 15 min, and imaged on a confocal microscope (LSM710,
Zeiss, Germany).
Whole-Cell Electrophysiology
Cardiac APs and ionic currents [INa, calcium current (ICa),
transient outward potassium current (Ito), and the inward
rectifier potassium current (IK1)] were recorded in the whole-cell
configuration at RT (22–23◦C) using a VE-2 amplifier (Alembic
Instruments, United States). Borosilicate glass pipettes were
pulled to a series resistance of ∼2 M. pClamp software,
version 8 (Axon Instruments, Union City, CA, United States)
was used for recordings. Data were analyzed using pClamp
software, version 8 (Axon Instruments) and OriginPro, version
7.5 (OriginLab Corporation, Northampton, MA, United States).
Current densities (pA/pF) were calculated by dividing the
peak current by the cell capacitance. For sodium currents,
current–voltage relationship curves (I–V) were fitted with
the equation, y = g∗(Vm−Vrev)/((1+exp[(Vm−V1/2)/K])). To
determine the voltage dependence of steady-state activation and
inactivation curves, the data from individual cells were fitted
with the Boltzmann equation, y = 1/(1+exp[(Vm−V1/2)/K]). Y
is the normalized current or conductance, Vm is the membrane
potential, V1/2 is the voltage at which half of the channels are
activated or inactivated, K is the slope factor, and Vrev the
reversal potential.
For cardiac AP recordings, cardiomyocytes were bathed in
a solution containing (in mM) NaCl 140, KCl 5.4, CaCl2 1.8,
MgCl2 1.2, HEPES 10, and glucose 5 (pH was adjusted to 7.4 with
NaOH). Cardiomyocytes were initially voltage-clamped (holding
potential −80 mV) and dialyzed with an internal solution
containing (in mM) KCl 120, CaCl2 1.5, MgCl2 5.5, Na2ATP
5, K2-EGTA 5, and HEPES 10 (pH was adjusted to 7.2 with
KOH). APs were elicited at 0.5 Hz with rectangular pulses (5 ms
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at 125% threshold) in current-clamp mode. Elicited APs were
allowed to stabilize before one or more sequences of ∼1 min
each were acquired from each cell. AP recordings were digitized
at a sampling frequency of 20 kHz. Electrophysiological data
were analyzed off-line, where the resting membrane potential,
amplitude, maximal upstroke velocity (dV/dt)max and durations
at 30, 50, and 90% repolarization were averaged from each
sequence of APs.
INa in α1-syntrophin knockdown (Snta1 fl/fl+) or
α1-syntrophin wild-type littermate (Snta1 fl/fl−) cardiomyocytes
were carried out using an internal solution containing (in
mM) CsCl 60, Cs-aspartate 70, CaCl2 1, MgCl2 1, HEPES 10,
EGTA 11, and Na2ATP 5 (pH was adjusted to 7.2 with CsOH).
Cardiomyocytes were bathed in a solution containing (in mM)
NaCl 5, NMDG-Cl 125, CaCl2 2, MgCl2 1.2, CsCl 5, HEPES 10,
and glucose 5 (pH was adjusted to 7.4 with CsOH). Nifedipine
(10 µM) and cobalt chloride (CoCl2) (10 µM) were added to the
extracellular solution in order to inhibit calcium currents.
To assess the functional consequences of detubulation,
currents carried by the calcium channel Cav1.2 (IBa) were
recorded using the internal pipette solution composed of (in mM)
60 CsCl, 70 Cs-aspartate, 1 MgCl2, 10 HEPES, 11 EGTA and
5 Mg-ATP (pH was adjusted to 7.2 with CsOH). The external
solution contained (in mM) 5 NaCl, 125 NMDG-Cl, 5.6 CsCl, 5
BaCl2, 1 MgCl2, 10 HEPES and 5 D-glucose (pH was adjusted to
7.4 with CsOH).
Ito and IK1 recordings were performed using an internal
solution containing (in mM): KCl 130, Mg-ATP 4, NaCl 12,
MgCl2 1, CaCl2 1, EGTA 10, and HEPES 10 (pH was adjusted to
7.2 with KOH). Myocytes were bathed with a solution containing
(in mM): NaCl 140, KCl 5.4, CaCl2 1.8, MgCl2 1, HEPES 10, and
Glucose 5 (pH was adjusted to 7.4 with NaOH). Voltage-gated
sodium channels were blocked with 50 µM of Tetrodotoxin
(TTX). L-type voltage-gated calcium channels were blocked
with 3 mM CoCl2. IK1 barium-sensitive current was calculated
by subtracting potassium current recorded after perfusion of
an extracellular solution containing 100 µM barium chloride
(BaCl2) from potassium current recorded before application of
BaCl2.To record Ito, 100 µM BaCl2 was added to the extracellular
solution to block IK1 current. I–V curves were not fitted.
Terminology: MaxI corresponds to the maximum current (in
absolute value) recorded during the protocol used to determine
the relationship between currents and membrane voltages (IV
curve). For INa, this is the maximum inward current recorded.
For Ito, the maximum current is the outward current measured
for a membrane voltage of +50 mV. For IK1, the maximum
current is the inward current measured for a membrane
voltage of−130 mV.
Cell-Attached Electrophysiology
INa macro recordings were recorded in the cell-attached
configuration either on the lateral membrane of cardiomyocytes
or on plasma membrane of HEK-293 cells transiently expressing
Nav1.4. All cell-attached recordings were performed at RT
(22–23◦C), using a low-noise Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA, United States). Borosilicate
glass pipettes were pulled to a series resistance of ∼1.5 M
(diameter of opening ∼20 µm2). No statistical difference was
noticed in averages pipette resistance between all conditions
indicating that a similar membrane areas was patched. The
internal pipette (intrapipette) solution was composed of (in
mM) 148 NaCl, 1.8 CaCl2, 1 MgCl2, 5 D-glucose, and 10 HEPES
(pH was adjusted to 7.4 with NaOH). The external solution,
to depolarize the cell membrane ∼0 mV, contained (in mM)
125 KCl, 30 KOH, 10 EGTA, 2 CaCl2, and 5 HEPES (pH was
adjusted to 7.15 with KOH). TTX-sensitive voltage-gated sodium
channels (Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7)
were inhibited by 50 nM TTX in the intrapipette solution.
A 4-pole Bessel low-pass filter at 2 kHz, was applied during
the recording and a sampling rate of 20 kHz was used for the
acquisition of the raw traces. P over 4 protocol was applied.
pClamp software, version 8 (Axon Instruments, Union City,
CA, United States) was used for recordings. Data were analyzed
using pClamp software, version 8 (Axon Instruments) and
OriginPro, version 7.5 (OriginLab Corporation, Northampton,
MA, United States). I–V sodium currents curves were fitted
with the equation, y = g∗(Vm−Vrev)/(1+exp[(Vm−V1/2)/K]).
To determine the voltage dependence of steady-state activation
and inactivation curves, the data from individual cells were fitted
with the Boltzmann equation, y = 1/(1+exp[(Vm−V1/2)/K]). Y
is the normalized current or conductance, Vm is the membrane
potential, V1/2 is the voltage at which half of the channels are
activated or inactivated, K is the slope factor, and Vrev the
reversal potential.
Single channel barium recordings have been performed in
cell-attached configuration. Average pipette size was 1.5 M.
Currents were measured at RT (22–23◦C) using a low-noise
Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA,
United States). The internal pipette solution was composed of
(in mM) 110 BaCl, 10 TEA-Cl, and 5 HEPES (pH was adjusted
to 7.4 with NMDG-OH). To depolarize the cell membrane ∼0
mV, the external solution contained (in mM) 125 KCl, 30 KOH,
10 EGTA, 2 CaCl2, and 5 HEPES (pH was adjusted to 7.15 with
KOH). A 4-pole Bessel low-pass filter at 2 kHz was applied during
the recording at sampling rate of 20 kHz for the acquisition
of raw traces. For each cell, a single depolarizing protocol at
−10 mV from a holding potential at −120 mV was applied at
least 150 times. Post-acquisition, data were filtered using a low
pass Gaussian filter and analyzed using pClamp software, version
9.2 (Axon Instruments, Union City, CA, United States).
Proximity Ligation Assay
Duolink R© (Olink Bioscience, Uppsala, Sweden) is a proximity
ligation assay (PLA) that enables the visualization of
protein-protein interactions allowing the in situ detection of
epitopes that are near each other (<40 nm apart). Two primary
antibodies raised in different species recognize the target antigen
or antigens of interest. Species-specific secondary antibodies,
called PLA probes, each with a unique short DNA strand
attached to it, bind to the primary antibodies. When PLA probes
are nearby, the DNA strands can interact through subsequent
addition of two other circle-forming DNA oligonucleotides. After
joining of the two oligonucleotides by enzymatic ligation, they
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are amplified via rolling circle amplification using a polymerase.
After the amplification reaction, several-hundredfold replication
of the DNA circle has occurred, and labeled complementary
oligonucleotide probes highlight the product. The resulting
high concentration of fluorescence in each single-molecule
amplification product is easily visible as a distinct bright dot
when viewed with a fluorescence microscope. Experiments were
performed according to the manufacturer’s recommendations.
Briefly, isolated mouse ventricular cardiac cells were fixed in 4%
paraformaldehyde for 10 min and incubated twice for 7 min in
PBS with 0.02% Triton X-100 at RT. Subsequently, cells were
incubated 15 min in blocking solution containing 1% bovine
serum albumin (BSA). Cardiomyocytes from α1-syntrophin
knockdown or α1-syntrophin wild-type littermate were then
incubated with commercially available mouse monoclonal anti-
pan-syntrophin and polyclonal anti-Nav1.5 primary antibodies
as specified below at a dilution of 1/100 and 1/200, respectively.
Subsequent incubation steps were performed at 37◦C and the
appropriate washing buffers were used after each incubation, as
specified in the protocol. After washing 3 times in PBS to remove
the primary antibody, Duolink R© secondary antibodies conjugated
to PLA probes were added to the tissue for a 1 h incubation. These
PLA probes consist of oligonucleotides that were subsequently
joined together in a circle after the addition of a ligation solution
(containing ligase enzyme) and incubation for 30 min. Next,
the rolling circle amplification of this circular template was
achieved by the addition of an amplification solution, containing
polymerase, and fluorescently labeled oligonucleotides, which
hybridized to the circular template during a 100 min incubation.
Samples were then mounted with Duolink R© in situ mounting
medium with DAPI (1 µl/200 µl PBS) and viewed with a confocal
microscope (LSM710, Zeiss, Germany).
Protein Extraction and Western Blots
Whole hearts were extracted from mice and the atria were
removed before homogenization of the ventricles in 1.5 mL
lysis buffer (50 mM HEPES, 150 mM NaCl, 1 mM EGTA,
10% glycerol, 1.5 mM MgCl2, and Complete R© protease inhibitor
cocktail from Roche, Basel, Switzerland) using a Polytron. Triton
X-100 was then added to make a final concentration of 1%
(final volume 3 mL) before lysis of the samples on a rotating
wheel for 1 h at 4◦C. Soluble fractions of the mouse heart were
obtained by subsequent centrifugation for 15 min at 13,000 rpm
at 4◦C. To determine the correct volume of sample needed
to load equivalent amounts of protein on a gel, the protein
concentration of each of the lysate samples was measured in
triplicate by Bradford assay and interpolated by a BSA standard
curve. Samples were denatured at 95◦C for 5 min before loading
them on a gel. To analyze and compare protein content in whole
mouse hearts, 25 or 50 µg of ventricular mouse heart lysate
samples were loaded on a 1.0 mm-thick 10% Tris–acetate gel for
high molecular weight proteins (Invitrogen). Gels were run at
150 V for 1 h and then subsequently transferred to nitrocellulose
membranes using the Biorad Turbo Transfer System (Biorad,
Hercules, CA, United States). All membranes were stained with
Ponceau as a qualitative check for equivalent loading of total
protein. Membranes were then rinsed twice with PBS before
using the SNAP i.d. system (Millipore, Zug, Switzerland) for
western blotting. 1% BSA was used as a blocking solution and
incubated with membranes for 10 min before incubation with the
primary antibodies for 10 min. Membranes were subsequently
washed four times in PBS + 0.1% Tween before incubating
with fluorescent secondary antibodies for 10 min. After four
more washes with PBS + 0.1% Tween and three washes in
PBS, membranes were scanned with the Odyssey R© Infrared
Imaging System (LI-COR Biosciences, Bad Homberg, Germany)
for detection of fluorescent protein.
Immunocytochemistry
Following cardiomyocyte isolation, cells from α1-syntrophin
knockdown and α1-syntrophin wild-type littermate hearts were
fixed with cold methanol at −20◦C for 10 min. Cells were
subsequently washed twice in PBS before permeabilization
with PBS containing 0.02% Triton X-100 for 14 min. Then,
the cardiomyocytes were blocked for 15 min at RT with
10% goat serum in TBS containing 2.3% of fab fragment
donkey anti-mouse IgG (H+L) (Jackson Immuno Research,
Baltimore, United States) at 1.3 mg/mL. Cardiomyocytes were
then incubated overnight with primary antibodies diluted in 3%
goat serum in TBS containing 0.02% Triton X-100. Afterward,
cells were washed four times with 3% goat serum in TBS for
5 min each, and then incubated with secondary antibodies for
2 h at RT. Cells were then washed four times in PBS (5 min
each). Finally, DAPI solution (1 µl/200 µl PBS) was applied
on cardiac cells for 20 min at RT. Before examination with the
confocal microscope (LSM710, Zeiss, Germany), cardiomyocytes
were embedded in FluorSaveTM Reagent (Calbiochem). Total
signal intensity was calculated using Zen 2.1 software version 11
from Carl Zeiss (Germany).
Antibodies
For western blots, the antibody against pan-syntrophin (MAI-
745, Affinity BioReagents, Golden, CO, United States) was used at
a dilution of 1/200. A custom rabbit polyclonal antibody against
α1-syntrophin (Pineda Antibody Service, Berlin) was used at a
dilution of 1/1000. The antibodies against Cre (69050; Novagen,
EMD Millipore-MERK, Schaffhausen, Switzerland) was used at
a dilution of 1/500 and the antibody against calnexin (C4731;
Sigma-Aldrich, St. Louis, MO, United States) was used at 1/1000.
For Duolink R© experiments, the antibody against syntrophin
(pan-syntrophin, MAI-745, Affinity BioReagents, Golden, CO,
United States) was used at a dilution of 1/100 and custom
rabbit polyclonal antibody against Nav1.5 (Pineda Antibody
Service, Berlin) was used at a dilution of 1/200. For staining, the
anti-pan-syntrophin antibody (MAI-745, Affinity BioReagents,
Golden, CO, United States) was used at a dilution of 1/200. The
antibody against Cre (69050; Novagen, EMD Millipore-MERK,
Schaffhausen, Switzerland) was used at a dilution of 1/1000.
Drugs
TTX was purchased from Alomone Labs (Jerusalem, Israel) and
dissolved in intrapipette solution. The µ-conotoxin CnIIIC was
purchased from Smartox (Saint Martin d’Heres, France) and
dissolved in water.
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FIGURE 1 | α1-Syntrophin expression in wild-type and knockdown
α1-syntrophin knockdown tissues. (A) Western blots of whole hearts from
wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown (Snta1
fl/fl+) mice show a significant decrease of the α1-syntrophin protein
(anti-Sntα1 antibody) and the absence of compensatory effects via other
syntrophin isoforms (anti-pan-syntrophin (Snt) antibody). (B) Western blots
from brain, liver and muscle from wild-type (Snta1 fl/fl−) and α1-syntrophin
cardiac specific knockdown (Snta1 fl/fl+) mice show no effect on
α1-syntrophin protein in other organs than the heart.
Statistical Analyses
Data are represented as means ± S.E.M. Statistical analyses
were performed using Prism7 GraphPadTM software. A Mann–
Whitney U two-tailed test was used to compare two groups due
to the small samples size. p< 0.05 was considered significant.
RESULTS
Characterization of a Cardiac-Specific
α1-Syntrophin Knockdown Mouse Tissue
and Cells
The remaining INa at the lateral membrane of Nav1.5 1SIV
mouse cardiomyocytes (Shy et al., 2014) raised the question
which molecular determinants are involved in this lateral
membrane pool of Nav1.5 channels. Although the Nav1.5
SIV motif mediates the interaction with α1-syntrophin
of the dystrophin–syntrophin complex, Nav1.5 contains
a similar motif (Ser-Leu-Ala) in its N-terminal domain,
which was previously shown to interact with α1-syntrophin
(Matamoros et al., 2016). Motivated by these observations,
we generated a cardiac-specific α1-syntrophin knockdown
mouse strain (described in Supplementary Figure S1) and
investigated the consequences of α1-syntrophin knockdown
on the INa of ventricular cardiomyocytes. Using either
pan-syntrophin (targetting all members of the syntrophin
family) or α1-syntrophin antibodies, western blots confirmed
the cardiac-specific reduction of the α1-syntrophin expression
in Snta1 fl/fl+ cardiac tissues compared to the control Snta1
fl/fl− (Figures 1A,B). In addition, immunostaining experiments
using the pan-syntrophin antibody showed a significant
decrease of syntrophin expression in isolated ventricular
cardiomyocytes Snta1 fl/fl+ compared to Snta1 fl/fl− cardiac
cells (Figures 2A,B). Finally, PLA experiments showed a
substantial decrease of the interaction (based on the absence
of red dots) between Nav1.5 and α1-syntrophin in Snta1 fl/fl+
cardiomyocytes compared to the control, suggesting that
α1-syntrophin and Nav1.5 no longer interact in α1-syntrophin
knockdown cells (Figure 2C). In parallel to the molecular
characterization, functional investigations were performed.
Whole-cell INa was recorded in freshly isolated ventricular
cardiomyocytes. As shown in Figures 3A,B, comparing
knockdown cardiomyocytes to the wild-type cells, a significant
reduction of the INa was observed (Snta1 fl/fl− Max inward INa:
33± 2 pA/pF, n = 16; Snta1 fl/fl+ Max inward INa: 22± 2 pA/pF,
n = 13, p < 0.05), without alteration of either cell membrane
capacitance (Snta1 fl/fl−: 166 ± 8 pF, n = 16; Snta1 fl/fl+:
159 ± 12 pF, n = 13, p > 0.05) or INa biophysical properties
(Table 2, Figures 3A,B, and Supplementary Figure S2).
Cardiac AP recordings moreover did not show any alteration
of neither the resting membrane potential nor AP duration
(Table 1 and Figures 4A,C). Only the upstroke velocity was
significantly decreased in α1-syntrophin knockdown cells
compared to controls (Table 1 and Figures 4B,C). Using
heterologous expression systems, (Matamoros et al., 2016)
have also demonstrated that α1-syntrophin interacts with
Kv4.2/4.3 and Kir2.1 potassium channels, which conduct
the Ito and IK1 currents, respectively. Although the decrease
of the upstroke velocity of the AP suggests that only INa is
altered in α1-syntrophin knockdown conditions, we recorded
the Ito and IK1 currents in the absence of α1-syntrophin.
As shown in Figures 5, 6, no alteration was observed in
α1-syntrophin knockdown cells compared to the control for
both currents (Snta1 fl/fl− MaxIto at +50 mV: 51 ± 6 pA/pF
[176 ± 11 pF], n = 12; Snta1 fl/fl+ MaxIto at +50 mV:
50± 6 pA/pF [151± 11 pF], n = 13, p> 0.05; Figures 5A,B), and
(Snta1 fl/fl−MaxIK1 at−130 mV: 6.4± 0.6 pA/pF [183± 16 pF],
n = 12; Snta1 fl/fl+ MaxIK1 at −130 mV: 7.0 ± 0.6 pA/pF
[159 ± 10 pF], n = 15, p > 0.05; Figures 6A,B) suggesting that
mainly the Nav1.5-mediated current is down-regulated in this
α1-syntrophin knockdown model.
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FIGURE 2 | α1-Syntrophin staining in wild-type and knockdown α1-syntrophin knockdown cardiac sections and cardiomyocytes. (A) Immunostaining, using a
pan-syntrophin antibody, of syntrophin in wild-type (Snta1 fl/fl−) and cardiac-specific α1-syntrophin knockdown murine cardiomyocytes (mvm) (Snta1 fl/fl+).
(B) Intensity quantification of syntrophin signal of four cells confirming the significant decrease of syntrophin in knockdown mice. (∗p < 0.05). The number of cells is
indicated in parentheses. (C) Duolink R© experiments showing a significant decrease in interaction (red dots) between Nav1.5 and syntrophin in α1-syntrophin cardiac
specific knockdown cardiomyocytes (Snta1 fl/fl+) compared to wild-type (Snta1 fl/fl−).
INa at the Lateral Membrane of
α1-Syntrophin Knockdown
Cardiomyocytes
Using the cell-attached patch-clamp configuration, we then
recorded the INa specifically at the lateral membrane of
α1-syntrophin knockdown cardiomyocytes. As shown in
Figures 7A,B, using an intrapipette solution with 50 nM of
TTX to block TTX-sensitive sodium channels (see section
“Materials and Methods”), a sizable TTX-resistant sodium
current was recorded in α1-syntrophin knockdown myocytes
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FIGURE 3 | Sodium current measurements in in wild-type and knockdown α1-syntrophin knockdown cardiomyocytes. (A) Raw traces of whole-cell sodium currents
recorded in adult ventricular cardiomyocytes from wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown cardiomyocytes (Snta1 fl/fl+). (B), Whole-cell
sodium current I–V curves show a significant decrease in the current density in knockdown cardiomyocytes compared to wild-type littermate cells. (∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001). The number of cells is indicated in parentheses.
(Figures 7A,B). This INa is, however, smaller (without any
alteration of the main biophysical properties) than the
currents recorded in control cells (Snta1 fl/fl− Max inward
INa: 143 ± 18 pA, n = 16; Snta1 fl/fl+ Max inward INa:
105 ± 9 pA, n = 22, p < 0.05; glass pipette resistances: Snta1
fl/fl−: 1.41 ± 0.08 M, n = 16; Snta1 fl/fl+: 1.45 ± 0.05 M,
n = 22, p > 0.05; Table 2, Figures 7A,B, and Supplementary
Figure S3). Altogether, these results suggest that the reduction
of α1-syntrophin expression in ventricular cardiomyocytes
leads to a decrease of lateral membrane Nav1.5 currents
similar to the findings reported by Shy et al. (2014) in
1SIV mice.
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TABLE 1 | Cardiac action potential parameters.
Sntα1 fl/fl− Sntα1 fl/fl+
RMP (mV) −90 ± 1 (n = 21) −89 ± 1 (n = 22)
APD30 (ms) 3.6 ± 0.5 (n = 21) 4.2 ± 0.8 (n = 22)
APD50 (ms) 7.6 ± 1.1 (n = 21) 9.1 ± 1.7 (n = 22)
APD90 (ms) 35.5 ± 2.6 (n = 21) 33.2 ± 3.3 (n = 22)
dV/dt (mV/ms) 218 ± 7 (n = 21) 199 ± 5 (n = 22)∗
RMP, resting membrane potential; APD, action potential duration and maximum
upstroke velocity (dV/dt) calculated from ventricular cardiac action potentials
recorded in wild-type (Snta1 fl/fl−) and syntrophin knockdown (Snta1 fl/fl+)
cardiomyocytes. Number of cells in parenthesis. ∗p < 0.05.
INa From α1-Syntrophin Knockdown and
1SIV Cardiomyocytes
We then performed INa recordings using the cell-attached
patch-clamp configuration on isolated ventricular
cardiomyocytes from wild-type and 1SIV mice. Again,
similar to the observations by Shy et al. (2014), the TTX-resistant
maximum INa at the lateral membrane was significantly
decreased in 1SIV cardiomyocytes compared to controls
(wild-type Max inward INa: 198 ± 39 pA, n = 10; 1SIV Max
inward INa: 107 ± 14 pA, n = 13, p < 0.05; glass pipette
resistances: wild-type: 1.33± 0.09 M, n = 10;1SIV: 1.46± 0.04
M, n = 13, p > 0.05; Supplementary Figure S4). As already
reported, the biophysical properties (steady-state inactivation
and activation curves) did not differ between wild-type and1SIV
INa (Table 2 and Supplementary Figure S5; Shy et al., 2014).
Of note, the peak INa also did not differ significantly between
lateral membranes of 1SIV and α1-syntrophin knockdown
cardiomyocytes (1SIV Max inward INa: 100 ± 8 pA, n = 42;
Snta1 fl/fl+ Max inward INa: 116 ± 12 pA, n = 26, p > 0.05)
(Figure 8A). In summary, these results suggest that a sizable
fraction of the TTX-resistant INa at the lateral membrane of
ventricular cardiomyocytes depends neither on the Nav1.5 SIV
motif nor on α1-syntrophin.
Nav1.5 Channels and the Remaining INa
at the Lateral Membrane
Several studies reported that other Nav1.x isoforms may be
expressed in cardiac cells in addition to Nav1.5, such as Nav1.1
(Westenbroek et al., 2013), Nav1.2 (Stoetzer et al., 2016), Nav1.3
(Westenbroek et al., 2013), Nav1.4 (Westenbroek et al., 2013),
Nav1.6 (Westenbroek et al., 2013), and Nav1.8 (Yang et al., 2012).
Although we performed the aforementioned INa recordings in
the presence of 50 nM TTX, which efficiently inhibits Nav1.1
(IC50 ∼10 nM), Nav1.2 (IC50 ∼10 nM), Nav1.3 (IC50 ∼10 nM),
and Nav1.6 (IC50 ∼5 nM), INa from Nav1.4 (IC50 ∼25 nM)
and Nav1.8 (IC50 > 50 µM) could still be present. As shown
in Supplementary Figure S4, in recordings from 1SIV cells,
the I–V relationship presents the maximum INa at a membrane
voltage of around −30 mV. This suggests that the majority
of this remaining current is not carried by Nav1.8, whose
maximum current lies at more depolarized values (around 0 mV)
(Stroud et al., 2016). We then addressed the question whether
Nav1.4 contributes to the remaining current. HEK-293 cells were
transfected with a Nav1.4 construct, and currents were recorded
using the cell-attached patch-clamp approach in the presence of
several drugs. As shown in Supplementary Figure S6A, INa was
only recorded in cells transfected with Nav1.4 (Supplementary
Figure S6A). Addition of 50 nM TTX in the intrapipette solution
strongly decreased the Nav1.4 INa after 3 min of pipette seal
(H2O Max inward INa: 54 ± 21 pA, n = 7; TTX 50 nM Max
inward INa: 6 ± 3 pA, n = 9, p < 0.05) (Supplementary Figure
S6B). In parallel, 9 min after pipette seal, an intrapipette solution
containing 1 µM µ-conotoxin CnIIIC, a specific blocker of
Nav1.4 (IC50 ∼1.4 nM) compared to Nav1.5 (IC50 > 10 µM)
(Favreau et al., 2012), completely abolished Nav1.4 currents
(H2O Max inward INa: 45 ± 10 pA, n = 9; CnIIIC 1 µM Max
inward INa: 0 ± 0 pA, n = 9, p < 0.05; Figure 8B). Based on
these observations, an intrapipette cocktail solution containing
50 nM of TTX and 1 µM µ-conotoxin CnIIIC was then used
to repeat the INa recordings from the lateral membrane of 1SIV
cardiomyocytes. As shown in Figure 8C, 9 min after sealing the
pipette, no alteration of the INa amplitude was observed (H2O
Max inward INa: 54 ± 9 pA, n = 10; cocktail Max inward INa:
60 ± 10 pA, n = 10, p > 0.05; Figure 8C). These results suggest
that the remaining lateral membrane INa in1SIV cardiomyocytes
is mainly carried by Nav1.5 channels.
Role of T-Tubules in Generating the
Lateral Membrane INa
We then aimed to investigate whether lateral membrane
INa is of T-tubular origin, following a protocol described
TABLE 2 | Activation and steady state inactivation curve parameters.
Whole-cell Cell-attached Cell-attached
Snta1 fl/fl− Snta1 fl/fl+ Snta1 fl/fl− Snta1 fl/fl+ wild-type 1SIV
Activation
K 5.5 ± 0.3 (n = 16) 5.3 ± 0.3 (n = 13) 10.3 ± 0.5 (n = 16) 12.6 ± 2.6 (n = 22) 11.4 ± 1.2 (n = 8) 11.3 ± 0.9 (n = 11)
V1/2 (mV) −33.4 ± 0.9 (n = 16) −31.3 ± 1.2 (n = 13) −46.7 ± 1.9 (n = 16) −48.5 ± 1.1 (n = 22) −46.4 ± 2.4 (n = 8) −51.3 ± 1.4 (n = 11)
Inactivation
K 5.5 ± 0.2 (n = 15) 6.2 ± 0.1 (n = 12)∗ 8.4 ± 0.4 (n = 24) 9.0 ± 0.7 (n = 20) 8.4 ± 1.2 (n = 6) 9.4 ± 1.0 (n = 9)
V1/2 (mV) −78.4 ± 1.0 (n = 15) −76.6 ± 1.1 (n = 12) −93.0 ± 1.0 (n = 24) −94.5 ± 0.9 (n = 20) −102.2 ± 2.1 (n = 6) −100.5 ± 1.3 (n = 9)
Slope (K) and V1/2 calculated from ventricular sodium current recorded in wild-type (Snta1 fl/fl−), syntrophin knockdown (Snta1 fl/fl+), and 1SIV cardiomyocytes. Number
of cells in parenthesis. ∗p < 0.05.
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FIGURE 4 | Cardiac action potentials measurements in in wild-type and knockdown α1-syntrophin knockdown cardiomyocytes. (A) Raw traces of cardiac action
potential recorded in wild-type adult ventricular cardiomyocytes (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown cardiomyocytes (Sntα1 fl/fl+).
(B) Upstroke velocity of cardiac action potential recorded in A from wild-type adult ventricular cardiomyocytes (Snta1 fl/fl−) and α1-syntrophin cardiac specific
knockdown cardiomyocytes (Sntα1 fl/fl+) showing the slowing of the upstroke velocity in action potential from knockdown cardiomyocytes. (C) Cardiac action
potential parameters measured in wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown cardiomyocytes (Snta1 fl/fl+) reveal the significant decrease
of the maximal upstroke velocity.
by Brette et al. (2002) to detubulate cardiac ventricular cells.
As shown in Figure 9A, di-8-ANEPPS staining on living
non-detubulated wild-type mouse cardiomyocytes presented a
striated pattern reflecting the presence of T-tubules (Figure 9A).
This striated pattern was absent in detubulated wild-type
cells, validating the detubulation procedure (Figure 9A).
To assess the functional consequences of detubulation, we
first recorded the electrical capacitance of the cells, which
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FIGURE 5 | Potassium current Ito measurements in wild-type and knockdown α1-syntrophin knockdown cardiomyocytes. (A,B) Raw traces and potassium current
I–V relationships show that knockdown of α1-syntrophin has no effect on these parameters in cardiac cells. The number of cells is indicated in parentheses. The
dashed lines are drawn to connect data points and do not represent lines of best fit.
approximates the surface of the plasma membrane, and, as a
positive control, Cav1.2-mediated currents using Ba2+ as charge
carrier (Figures 9B–D). Detubulation significantly decreased the
capacitance of the cardiac cells by 30 ± 4%, (non-detubulated:
159 ± 14 pF, n = 7; detubulated: 111 ± 6 pF, n = 7, p < 0.05;
Figure 9B), and the maximum Ba2+ current by 57 ± 7%
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FIGURE 6 | Potassium current IK1 measurements in wild-type and knockdown α1-syntrophin knockdown cardiomyocytes. (A,B) Raw traces and potassium current
I–V relationships show that knockdown of α1-syntrophin had no effect on these parameters in cardiac cells. The number of cells is indicated in parentheses. The
dashed lines are drawn to connect data points and do not represent lines of best fit.
(non-detubulated Max inward IBa: 4377 ± 270 pA, n = 7;
detubulated Max inward IBa: 1879 ± 306 pA, n = 7, p < 0.05;
Figure 9C). Consequently, the Ba2+ current density (pA/pF) was
also significantly decreased by 42 ± 9 % (non-detubulated Max
inward IBa: 29 ± 3 pA/pF, n = 7; detubulated Max inward IBa:
17 ± 3 pA/pF, n = 7, p < 0.05; Figure 9D). These results validate
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FIGURE 7 | Lateral sodium currents measurements in cell-attached configuration in wild-type and α1-syntrophin knockdown cardiomyocytes. (A), Raw traces of
cell-attached sodium currents recorded from adult ventricular cardiomyocytes from wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown
cardiomyocytes (Snta1 fl/fl+). (B) Sodium current I–V curves from α1-syntrophin cardiac specific knockdown cardiomyocytes (Snta1 fl/fl+) (•) reveal a decrease of the
lateral sodium current compared to the control (Snta1 fl/fl−) (◦).
the procedure of cardiomyocyte detubulation by formamide
treatment. Then, lateral INa was recorded in non-detubulated and
detubulated 1SIV cardiomyocytes. As shown in Figures 10A,B,
the maximum INa of detubulated cardiac cells compared to non-
detubulated cardiomyocytes was not modified (non-detubulated
Max inward INa: 95 ± 10 pA, n = 29; detubulated Max inward
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FIGURE 8 | Pharmacological characterization of the remaining sodium current at the lateral membrane of cardiomyocytes. (A) Plot chart showing the similarity in
average sodium currents recorded at the lateral membrane of cardiomyocytes from 1SIV and α1-syntrophin cardiac specific knockdown (Snta1 fl/fl+)
cardiomyocytes using cell-attached configuration. (B) µ-conotoxin CnIIIC (CnIIIC) mediated the reduction in Nav1.4 INa after 9 min of application in HEK-293 cell line.
(C) Tetrodotoxin (TTX) and µ-conotoxin CnIIIC (CnIIIC) did not mediate any effect on INa recorded on the lateral membrane of 1SIV cardiomyocytes using the
cell-attached configuration (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). The number of cells is indicated in parentheses.
INa: 80 ± 6 pA, n = 29, p > 0.05; Figures 10A,B). These
findings suggest that the remaining lateral membrane INa in
1SIV myocytes is not carried by Nav1.5 channels in the T-tubular
system, but rather by a distinct lateral membrane pool of Nav1.5
channels that is independent of the PDZ-binding motif SIV.
Assessing the T-Tubular Pool of Ion
Channels Using the Cell-Attached Patch
Clamp Configuration
Lastly, we assessed whether the cell-attached patch-clamp
configuration allows the recording of T-tubular currents. In
theory, the pipettes used in this study had an opening large
enough (∼20 µm2) to catch the mouth of 3–5 T-tubules.
We recorded ICa from lateral membrane on wild-type
ventricular myocytes using an intrapipette solution with
only barium as the charge carrier. Note that most of the cardiac
voltage-gated calcium channels Cav1.2 are located in T-tubules
(Kawai et al., 1999). Contrary to the expected macroscopic ICa,
only single-channel current activities were observed, most likely
arising from calcium channels (Figures 11A,B). To characterize
these currents, 3 µM of the calcium channel opener Bay-K-8644
was added to the intrapipette solution. Bay-K-8644 significantly
increased the number of events (vehicle: 39,677 events, n = 3;
Bay-K-8644: 83,697 events, n = 3, p < 0.05; Figures 11A,B).
Altogether, these results demonstrate that the cell-attached
patch-clamp configuration on the lateral membrane does not
permit to investigate ion channels activity at the T-tubules, since
the size of the recorded ICa was much smaller than the one
expected from T-tubules.
DISCUSSION
The present study shows that (1) a distinct population of Nav1.5
channels at the lateral membrane of mouse cardiomyocytes
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FIGURE 9 | Validation of the detubulation procedure. (A) Confocal images showing detubulation mediated by formamide treatment on living cardiomyocytes.
(B) Effect of detubulation on cell capacitance (pF). (C,D) functional consequences of detubulation on barium currents (IBa) carried by calcium channels. (∗∗p < 0.01,
∗∗∗p < 0.001). The number of cells is indicated in parentheses.
does not depend on either the PDZ-binding SIV motif or
the α1-syntrophin protein; (2) the remaining INa at the lateral
membrane of Nav1.5 1SIV myocytes is carried by sodium
channels that are most likely not located in the T-tubules; (3)
the identity of this sub-pool of sodium channels remaining at the
lateral membrane is probably Nav1.5; and (4) the cell-attached
patch-clamp configuration does not allow the investigation of ion
channels expressed in the T-tubular system.
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FIGURE 10 | Effects of the detubulation on lateral sodium current. (A) Raw traces of cell-attached sodium currents recorded from non-detubulated and detubulated
1SIV adult ventricular cardiomyocytes. (B) Consequences on peak current amplitudes of detubulation on lateral sodium currents from 1SIV cardiomyocytes. The
number of cells is indicated in parentheses.
Although other Nav1.x channels (so-called neuronal isoforms)
have been proposed to be expressed in the T-tubular system,
recent transcriptomic analyses from freshly isolated murine
ventricular myocytes suggests that only transcripts encoding
Nav1.5 and Nav1.4 channels are significantly expressed (Chevalier
et al., 2018). However, the presence of a Nav1.5 channel
population in T-tubules of murine cardiomyocytes is still an open
question. In ventricular cardiomyocytes, the punctate pattern
observed in staining by Shy et al. and colleagues suggesting
the presence of Nav1.5 channels inside the T-tubules could be
due to either their presence at the Z-line level, a structure
close to the T-tubules, or unspecific staining (Ziane et al.,
2010; Shy et al., 2014). Cell-attached patch-clamp configuration
on lateral membrane of wild-type and detubulated ventricular
cardiomyocytes to record sodium currents has been proposed
as an approach to decipher if sodium channels are expressed in
T-tubules. Assuming that the T-tubular system accounts for an
important percentage of the cell surface area,∼30% decrease after
detubulation of the cell capacitance measured in this study and
in others suggest a poor detubulation procedure that may lead
to a misinterpretation the results (Brette et al., 2002). Optical
measurements have shown that a decrease of 32% of the cell
capacitance, after formamide detubulation, corresponds de facto
to 65% decrease of the cell surface area (Pasek et al., 2008).
Based on these data, the results presented in Figure 10 clearly
suggest that the cell-attached configuration does not allow the
recording of the activity of sodium channels located in T-tubules.
This conclusion is also supported by the recordings of unitary
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FIGURE 11 | Calcium current recordings and cell-attached configuration. (A) Single currents recorded using cell-attached configuration on the lateral membrane of
wild-type cardiomyocytes with only calcium inside the pipette. The calcium channel opener Bay K-8644 affects calcium currents, suggesting that this single current
is a calcium current. (B) Quantification of events observed in panel (A) without (◦) or with (•) Bay K-8644. The number of cells is indicated in parentheses.
calcium conductances (as in Figure 11) that are most likely
reflecting Cav1.2 channel activity around the opening of T-tubule
as reported by Lab et al. (2013).
The novel findings from the cardiac-specific α1-syntrophin
knockdown mouse line suggest that the remaining INa at the
lateral membrane is indeed independent of the interaction
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between α1-syntrophin with the Nav1.5 C-terminal SIV motif
or, as Shy et al. (2014) and Matamoros et al. (2016) proposed,
via the N-terminal SLA motif. Surprisingly, the decrease of
the lateral membrane INa is somewhat less pronounced in α1-
syntrophin knockdown than in 1SIV cardiomyocytes suggesting
that the SIV-motif may interact with other partners. However,
one has to take into account that both mouse lines are
on different genetic backgrounds. Therefore, caution should
be taken before comparing these two set of data. Further
experiments using a double 1SIV-α1-syntrophin knockdown
mouse model will have to be carried out to challenge this
question. Such experiments would indubitably show whether the
remaining INa at the lateral membrane is independent of both the
SIV motif and α1-syntrophin.
It may seem surprising that the AP duration in cardiac-specific
α1-syntrophin knockdown myocytes was not prolonged. It
has been reported that mutations in the gene coding for
α1-syntrophin lead to an increase of the late sodium current,
and hence prolong the AP duration (Ueda et al., 2008; Cheng
et al., 2009). This mechanism has been proposed to be caused
by a decrease of interaction between mutant α1-syntrophin and
the plasma membrane Ca2+ ATPase subtype 4b (PMCA4b)
and scavenging nNOS. The concomitant upregulation of nNOS,
and hyper-S-nitrosylation of Nav1.5 channel was proposed
to underlie the increase of the late sodium current (Ueda
et al., 2008; Cheng et al., 2009). Since in the α1-syntrophin
knockdown model of this study the syntrophin protein is
absent (Figures 1A, 2A), we speculate that the macro-
molecular complex comprising Nav1.5, PMCA4b, nNOS, and
α1-syntrophin is entirely dissociated. This may explain why no
effect on the cardiac AP duration was observed.
The finding that only INa and not Ito and IK1 was altered in
α1-syntrophin knockdown cardiomyocytes is at odds with the
recent studies by Iwata et al. (2005) and Matamoros et al. (2016).
This discrepancy may reflect fundamental differences when
studying ion channel regulation using in vitro vs. in vivo models
as already observed with the regulation of Nav1.5 by SAP97
(Petitprez et al., 2011; Milstein et al., 2012; Gillet et al., 2015;
Matamoros et al., 2016). It appears unlikely that the remaining
sodium channels at the lateral membrane interacts with other
syntrophin isoforms since α1-syntrophin accounts for ∼90% of
all syntrophin mRNA expressed in murine cardiac cells (Iwata
et al., 2005; Chevalier et al., 2018). However, further experiments
have to be performed using all-syntrophin isoform knockdown
mouse strain to challenge this possibility. Moreover, although
western blots and immunostaining experiments strongly suggest
that α1-syntrophin expression is almost completely abolished,
we cannot exclude the option that a very low amount of
α1-syntrophin is still present in the knockdown model, which
could contribute to a small portion of the remaining lateral
membrane INa.
The main limitations of the present study are primarily
related to the methodological approaches. Future
experiments could investigate the precise localization of
these syntrophin-independent sub-pools of Nav1.5 channels
at the lateral membrane using the scanning ion conductance
microscopy (SICM) method. In addition, the different techniques
used in this study were insufficient to unequivocally demonstrate
whether Nav1.5 channels are present or absent inside T-tubules.
Furthermore, when interpreting these data, we have to keep
in mind that the compartmentalization of sodium channels
in cardiomyocytes may be species-dependent. Using a similar
approach as in the present study, Verkerk et al. (2007)
showed that TTX-resistant voltage-gated sodium channels
including Nav1.5 are absent at the lateral membrane of rabbit
ventricular cardiomyocytes.
In summary, these results suggest the presence of a sub-
pool of Nav1.5 channels at the lateral membrane of murine
cardiomyocytes, outside the T-tubules, that is independent of
α1-syntrophin and the SIV motif of Nav1.5. Future experiments
will help to understand the functional roles of these distinct
pools of sodium channels in specific membrane compartments
of cardiomyocytes.
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FIGURE S1 | Generation of the Snta1-flox mouse model. (A) The diagram shows
homologous recombination of the Snta1 locus (Snta1-WT) with the targeting
vector pSnta1-TV and the resulting targeted Snta1 alleles. Two loxP sites are
inserted into the Snta1 locus, flanking a region of 0.7 kb that contains part of exon
1 of Snta1. One loxP site is inserted into the 5′ untranslated region (5′ UTR) of
exon 1, whereas the second site is located in intron 1. Directly upstream of the 3′
loxP site, a neomycin resistance cassette (neo) is inserted, which is flanked by
FRT-sites, the recognition sites for the Flp-recombinase (Snta1-neoflox allele).
Upon breeding to Flp-deleter mice, the neomycin resistance cassette is deleted,
and only a single FRT site is remaining in the Snta1-flox allele. The short (SA) and
long homology regions (LA) are indicated as gray boxes. Positions of primers and
sizes of products for genotyping PCR, as well as restriction sites and the probes
for Southern blot analyses, are indicated. (B) Representative result of Southern
blot analysis with genomic DNA from Snta1 wt/wt and Snta1 neoflox/wt (1C9) ES
cells cut with PstI and probed using either a sequence upstream of exon 1 or
downstream of exon 2 of Snta1. This resulted in a 14.3 kb signal for the wild-type
allele with both probes and either a 4.7 kb signal for the 5′ probe and a 9.0 kb
signal for the 3′ probe in the Snta1-neoflox allele. (C) PCR analysis of all three
genotypes using the primer depicted in A. The wild-type (WT) allele resulted in a
PCR product of 274 bp, whereas a 443 bp fragment was generated for the
Snta1-flox allele (Flox).
FIGURE S2 | Whole-cell biophysical properties of wild-type and Snta1-flox
cardiomyocytes. (A,B) Activation (A) and steady-state inactivation curves (B)
calculated from whole-cell recordings of sodium currents show no
alteration of the biophysical properties between adult ventricular
cardiomyocytes from wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific
knockdown cardiomyocytes (Snta1 fl/fl+). The number of cells is
indicated in parentheses.
FIGURE S3 | Cell-attached biophysical properties of wild-type and Snta1-flox
cardiomyocytes. (A,B) Activation (A) and steady-state inactivation curves (B)
calculated from cell-attached recordings of sodium currents show no alteration of
the biophysical properties between adult ventricular cardiomyocytes from
wild-type (Snta1 fl/fl−) and α1-syntrophin cardiac specific knockdown
cardiomyocytes (Snta1 fl/fl+). The number of cells is indicated in parentheses.
FIGURE S4 | Lateral sodium current measurements in wild-type and 1SIV
cardiomyocytes. (A) representative cell-attached recordings of sodium currents
from the lateral membrane of wild-type and 1SIV cardiomyocytes. (B)
Current-voltage (I–V) curve showing a significant decrease in the sodium current
recorded in 1SIV cardiomyocytes (•) compared to the control (◦) (∗p < 0.05). The
number of cells is indicated in parentheses.
FIGURE S5 | Cell-attached biophysical properties of wild-type and 1SIV
cardiomyocytes. (A,B) Activation (A) and steady-state inactivation curves (B)
calculated from cell-attached recordings of sodium currents show no alteration of
the biophysical properties between adult ventricular cardiomyocytes from
wild-type and 1SIV cardiomyocytes. The number of cells is
indicated in parentheses.
FIGURE S6 | Pharmacological block of Nav1.4 current in HEK-293 cells. (A)
Representative cell-attached Nav1.4 currents recorded in transiently transfected
HEK-293 cells. (B) INa reduction mediated by tetrodotoxin (TTX) after 3 min of
application (∗∗p < 0.01). The number of cells is indicated in parentheses.
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